ANDA 207061, held by Jubilant Generics. Celecoxib.
As of Nov 15, 2026, ANDA 207061 (Celecoxib), held by Jubilant Generics, was first approved by FDA on Apr 4, 2017, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 4, 2017 | Original application | Approved | None posted |
| Dec 10, 2018 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 4, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters